Grover Jewells IPO...
31 Jan, 2026
Gujarat Kidney & Super Speciality IPO
Gujarat Kidney IPO is a book-building issue of ₹250.80 cr, which is entirely a fresh issue. The IPO price band is set at ₹108 to ₹114 per share and the minimum amount of investment required by an individual investor is ₹14,592 (128 shares), which will be listed on the platforms BSE, NSE with a tentative listing date. The lot size for an application is 128. The IPO subscription will open on December 22, 2025 and closes on December 24, 2025.
Company Background
Gujarat Kidney and Super Speciality Ltd. was incorporated in 2019. It is a leading healthcare central region in Gujarat, offering comprehensive multispeciality services across secondary and tertiary care. The company operates seven hospitals and four pharmacies, with a total bed capacity of 490, supporting advanced medical care across Vadodara, Godhra, Bharuch, Borsad and Anand. These hospitals provide a wide range of services, including general and surgical treatments, super speciality procedures, orthopaedics, joint replacement, obstetrics and gynaecology, cardiology and diabetology. As of June 30, 2025, their team comprised 89 doctors, 332 nurses and 338 support staff, delivering high-quality patient care across multiple locations.
Operations and Product Range
Facility and Production
They operate multispeciality hospitals and pharmacies across Gujarat, with a total bed capacity of 490 (340 operational). The facilities provide secondary and tertiary care, including super-speciality surgeries, orthopaedics, cardiology, joint replacement, and obstetrics. Supported by 89 doctors, 332 nurses, and 338 staff, the hospitals ensure high-quality patient care.
Brands and Market Presence
This company has established a strong presence in Gujarat’s healthcare sector through its seven hospitals and four pharmacies. Operating under well-recognised names like Gujarat Kidney and Superspeciality Hospital and Ashwini Medical Centre, the company delivers trusted secondary and tertiary care, building a reputable brand across multiple cities and enhancing accessibility to quality healthcare.
Revenue Channels
- • Fee from the patient care service, including general and speciality surgery treatment.
- • Fees from diagnostic and laboratory services.
- • Sale revenue through company-operated pharmacies.
Management and Shareholding
Promoters and Shareholding
The promoters and shareholders are experienced healthcare professionals and business leaders committed to expanding quality healthcare services in Gujarat. The promoters hold a significant stake in the company, ensuring strategic control and long-term vision, while the remaining shareholding may include institutional investors, private investors and other stakeholders supporting the company’s growth and operations.
Board Members
The board members of this company comprise experienced professionals from healthcare, management, and finance domains. They provide strategic guidance, oversee corporate governance and drive the company’s growth and operational excellence. Also, the promoters, along with independent directors who ensure compliance, transparency and sustainable development across all hospital and pharmacy operations.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Gujarat Kidney & Super Speciality IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Gujarat Kidney & Super Speciality IPO Details
| Detail | Description |
|---|---|
| IPO Date | 22 to 24 Dec, 2025 |
| Listing Date | [.] |
| Face Value | ₹2 per share |
| Issue Price Band | ₹108 to ₹114 |
| Lot Size | 128 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 2,20,00,000 shares (agg. up to ₹250.80 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 5,68,43,250 shares |
| Share Holding Post Issue | 7,88,43,250 shares |
Gujarat Kidney & Super Speciality IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Mon, Dec 22, 2025 |
| IPO Close Date | Wed, Dec 24, 2025 |
| Tentative Allotment | Fri, Dec 26, 2025 |
| Initiation of Refunds | Mon, Dec 29, 2025 |
| Credit of Shares to Demat | Mon, Dec 29, 2025 |
| Tentative Listing Date | Tue, Dec 30, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Dec 24, 2025 |
Gujarat Kidney & Super Speciality IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 1 | 128 | ₹14,592 |
| Individual investors (Retail) (Max) | 13 | 1,664 | ₹1,89,696 |
| S-HNI (Min) | 14 | 1,792 | ₹2,04,288 |
| S-HNI (Max) | 68 | 8,704 | ₹9,92,256 |
| B-HNI (Min) | 69 | 8,832 | ₹10,06,848 |
Gujarat Kidney & Super Speciality IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Promoter Holding Pre Issue | - |
| Promoter Holding Post Issue | - |
Competitive Strength:
- • Super speciality in urology with preeminence in renal sciences.
- • Light business model in the central region of Gujarat and a track record of performance and growth.
- • Experienced & Specialised team of doctors and nurses.
- • 7 multispeciality hospitals and 4 pharmacies in India.
Gujarat Kidney & Super Speciality IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun 2025 | 61.59 | 15.27 | 5.40 | 30.56 | - | 4.03 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2025 | 55.34 | 40.40 | 9.50 | 25.71 | - | 3.88 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2024 | 20.53 | 5.48 | 1.71 | 10.80 | - | 1.94 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 3.87 | 0.00 | -0.01 | 0.37 | - | - | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 36.61% |
| ROCE | 37.65% |
| Debt/Equity | 0.15 |
| RoNW | 36.61% |
| PAT Margin | 23.61% |
| EBITDA Margin | 41.12% |
| Price to Book Value | 22.62 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.85 | 2.74 |
| P/E (x) | 61.62 | 41.59 |
Gujarat Kidney IPO Proceeds
- • Proceeds will be used for repayment of the debt and part-payment of the purchase consideration of the company.
- • Funding of capital expenditure requirements of the company’s new projects.
- • Investment in new technology equipment.
- • General Corporate Purposes.
Conclusion
The Gujarat Kidney and Super Speciality IPO offers an opportunity for investors to participate in a growing company within the healthcare sector. With a strong presence across multiple cities in Gujarat, a diversified revenue model and a focus on secondary and tertiary care. This company combines operational strength with growth potential. The company’s robust infrastructure, experienced management, and strategic expansion plans position it well to capitalise on increasing healthcare demand, making it an attractive investment option for those seeking exposure to India’s expanding healthcare industry.
RHP:
View RHPDRHP:
View DRHPMerchant Banker
Read more :
Frequently asked Questions (FAQs )
-
What are the Gujarat Kidney and Super Speciality IPO dates and price band?
The IPO opens on December 22, 2025 and closes on December 24, 2025. The price band is set at ₹108 to ₹114 per share.
-
Where will the Gujarat Kidney and Super Speciality IPO be listed?
The IPO is expected to be listed on the BSE SME platform.
-
What does Gujarat Kidney and Super Speciality Limited do?
The company provides secondary and tertiary healthcare services, including super speciality surgeries and diagnostic care.
-
How much is the Gujarat Kidney and Super Speciality IPO size and issue type?
The IPO size is ₹250.80 cr and the issue type is Book-building IPO.
-
What is the lot size and minimum investment for the Gujarat Kidney and Super Speciality IPO?
The lot size for an application is 128 shares and the minimum investment required by an individual investor is ₹14,592.
-
How will the IPO proceeds be used?
The funds raised through the IPO will be used for hospital expansion, technology development, debt repayment and general corporate purposes.
.jpg)
